Results 61 to 70 of about 4,485,992 (308)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Limits of predictability for large-scale urban vehicular mobility

open access: yes, 2014
Key challenges in vehicular transportation and communication systems are understanding vehicular mobility and utilizing mobility prediction, which are vital for both solving the congestion problem and helping to build efficient vehicular communication ...
Chen, Sheng   +4 more
core   +1 more source

Car-to-Pedestrian Communication Safety System Based on the Vehicular Ad-Hoc Network Environment: A Systematic Review

open access: yesInformation, 2017
With the unparalleled growth of motor vehicles, traffic accident between pedestrians and vehicles is one of the most serious issues in the word-wild. Plenty of injuries and fatalities are caused by the traffic accidents and crashes.
Peng Jing, Wei Huang, Long Chen
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Secure Multi-access Edge Computing Assisted Maneuver Control for Autonomous Vehicles

open access: yes, 2021
The sensing capabilities of smart vehicles are growing and enabling unprecedented functionalities that drive the future commercial adoption of autonomous vehicles.
Tesei A.   +3 more
core   +1 more source

Resilient in-network aggregation for vehicular networks [PDF]

open access: yes, 2015
Applications for vehicular ad hoc networks (VANETs) are an active field of re- search with the potential to significantly contribute to driver safety, traffic efficiency, and comfort. Messages are typically exchanged and forwarded between vehicles using wireless communication, thereby creating a wireless ad hoc network.
openaire   +2 more sources

An edge communication based probabilistic caching for transient content distribution in vehicular networks

open access: yesScientific Reports, 2023
Vehicular Content Networks (VCNs) represent key empowering solution for content distribution in fully distributed manner for vehicular infotainment applications.
Divya Gupta   +3 more
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Software-Defined Approach for Communication in Autonomous Transportation Systems

open access: yesEAI Endorsed Transactions on Energy Web, 2017
Autonomous driving technology offers a promising solution to reduce road accidents, traffic congestion, and fuel consumption. The management of vehicular networks is challenging as it demands mobility, location awareness, high reliability and low latency
Piyush Dhawankar   +3 more
doaj   +1 more source

Paclitaxel induces NM2‐dependent cellular contraction through GEF‐H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells

open access: yesMolecular Oncology, EarlyView.
Taxanes are widely used chemotherapeutics whose effects on cellular mechanics remain poorly understood. We show that paclitaxel induces rapid cellular contraction by promoting GEF‐H1 dissociation from microtubules and non‐muscle myosin II activation through RhoA/ROCK.
Gloria Asensio‐Juárez   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy